Company news

Aurinia Pharmaceuticals Inc news in 2025

Aurinia Pharmaceuticals Inc's news releases, calls and decks from 2025, newest first.

View company

Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors

December 16, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

November 3, 2025

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

November 2, 2025

Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025

October 14, 2025

Aurinia Responds to Now Retracted LinkedIn Post

September 28, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

July 30, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

July 21, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

June 29, 2025

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

June 28, 2025

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

May 21, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 11, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

May 4, 2025

Glass Lewis Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting

April 30, 2025

ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting

April 29, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

February 26, 2025

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

February 19, 2025

Calls in 2025

Decks in 2025